Skip to main content
Download PDF

Prevalence of autism spectrum disorder in mainland china over the past 6 years: a systematic review and meta-analysis

BMC Psychiatry volume 24, Article number: 404 (2024) Cite this article

Abstract

Background

Coupled with its rising prevalence, Autism spectrum disorder (ASD) has become a globally recognized public health concern. Nevertheless, large-scale, multicenter studies that analyze the epidemiology of ASD in China are relatively scarce.

Methods

Literature searches were conducted in PubMed/Medline, Embase, the Cochrane Library, Wanfang Data Knowledge Service Platform, China Biology Medicine database (CBM), China Science and Technology Journal Database (CSTJ), and China National Knowledge Infrastructure (CNKI) to retrieve studies published before April 8, 2023, related to ASD prevalence among children aged 0 to 14 years in mainland China. Meta-analysis was conducted using RevMan 5.2 and Stata 14.0.

Results

Twenty-one articles were included. The ASD prevalence among children in mainland China has been 0.7% (95% confidence interval(CI): 0.006–0.008) since 2017. The prevalence of ASD among boys was 1.0% (95% CI: 0.008–0.011), which was significantly higher than that among girls at 0.2% (95% CI: 0.002–0.003), with a statistically significant difference (OR = 3.198, 95% CI: 2.489–4.109, P = 0.000). Among the included studies, 18 reported an ASD prevalence of 0.8% (95% CI: 0.007–0.010), while 3 studies reported an autistic disorder (AD) prevalence of 0.7% (95% CI: 0.006–0.008). The prevalence of autism among urban children was 23.9% (95% CI: 0.149–0.328), and in rural areas, it was 0.7% (95% CI: 0.002–0.013), with no statistically significant difference (OR = 1.342, 95% CI: 0.258–6.975, P = 0.727). Regression analysis showed that factors such as region (P = 0.000), age (P = 0.000), study period (P = 0.000), sample size (P = 0.000), sampling method (P = 0.002), population source (P = 0.000), disease type (P = 0.000), quality score of the study (P = 0.000), and diagnostic criteria (P = 0.000) might have contributed to the heterogeneity in ASD prevalence.

Conclusion

The prevalence of ASD in China from 2017 to 2023 was 7/1000, showing an upward trend compared to that before 2017 (26.50/10,000). The male-to-female prevalence ratio was 5:1.The overall prevalence remained significantly lower than that reported in foreign countries.

Peer Review reports

Background

Autism spectrum disorder (ASD) is a widespread neurodevelopmental disorder that primarily occurs in early childhood. It is also referred to as autism or autistic disorder. The main characteristics of ASD include difficulties in speech communication, impaired social interactions, restricted interests, repetitive behaviors, and often intellectual challenges. Subtypes of ASD include autistic disorder (AD), Asperger syndrome, and pervasive developmental disorder not otherwise specified (PDD-NOS) [1, 2]. Increasing evidence suggests that ASD frequently coexists with symptoms or conditions that cannot be solely explained by ASD itself, known as comorbidities. These comorbidities include attention-deficit hyperactivity disorder [3, 4], epilepsy [5, 6], sleep disorders [7, 8], and gastrointestinal issues [9,10,11]. Children with ASD often experience one or more coexisting conditions, which may vary over time and mutually influence each other, indicating a poorer prognosis for affected individuals [12].

ASD typically manifests before the age of 3 and substantially impacts the physical and mental health of children and adolescents. Due to its poor prognosis, high disability rate, and the need for long-term rehabilitation, ASD imposes considerable economic and psychological burdens on both society and families. Coupled with its rising prevalence, ASD has become a globally recognized public health concern [13]. Reported prevalence rates of ASD vary across different countries and regions. The global prevalence is estimated to be approximately 1% [14]. A study by Liu Xian et al. [15] reported an ASD prevalence of 26.50/10,000 in China from 2000 to December 2016. In 2023, the Autism and Developmental Disorders Monitoring Network (ADDM) in the United States released data for 11 states in 2020, showing an overall ASD prevalence of 27.6/1000 aged 0–8 years (1/36) [16]. This marked an increase of 17.8% from the 2018 prevalence of 22.7/1000 (1/44) [17] and a 32.97% increase from the 2016 prevalence [18] of 18.5/1000 (1/54).

Currently, reports on ASD prevalence or screening rates vary in different regions within China. For instance, Zheng Kai et al. [19] reported an ASD prevalence of 1.15/1000 in the Ningbo region, while Deng Cheng et al. [20] found a positive ASD screening rate of 10.2/1000 preschool children in Zhongshan city. Nevertheless, large-scale, multicenter studies that analyze the epidemiology of ASD in China are relatively scarce. This study aimed to comprehensively analyze the relevant literature through quantitative methods, exploring the recent prevalence of ASD among children in mainland China. The goal is to provide evidence-based data support for assessing health care service demands and developing interventions, treatments, and further research endeavors.

Methods

Literature search strategy

Computerized database search

We conducted searches in databases including PubMed/Medline, Embase, the Cochrane Library, Wanfang Data Knowledge Service Platform, China Biology Medicine database (CBM), China Science and Technology Journal Database (CSTJ), and China National Knowledge Infrastructure (CNKI). Additionally, we traced the references of the included studies. The search period was limited to records published up to May 8, 2023. The search strategy involved a combination of subject terms and free-text keywords. Furthermore, relevant references from the included studies were manually searched.

The English search terms used were “Autistic Disorder,” “Autism,” “Disorder, Autistic,” “Disorders, Autistic,” “Kanner’s Syndrome,” “Kanner Syndrome,” “Autism, Infantile,” “Infantile Autism,” “Autism, Early Infantile,” “Early Infantile Autism,” “Infantile Autism, Early,” “autism spectrum disorder,” “Asperger,” “Asperger syndrome,” “childhood disintegrative disorder,” “pervasive developmental disorder not otherwise specified,” “Rett syndrome,” “PDD-NOS,” “China,” and “Chinese.”

Using PubMed/Medline as an example, the search query was as follows:

(“Autistic Disorder“[Mesh]) OR “Autism“[All Fields] OR “Disorder, Autistic“[All Fields] OR “Disorders, Autistic“[All Fields] OR “Kanner’s Syndrome“[All Fields] OR “Kanner Syndrome“[All Fields] OR “Autism, Infantile“[All Fields] OR “Infantile Autism“[All Fields] OR “Autism, Early Infantile“[All Fields] OR “Early Infantile Autism“[All Fields] OR “Infantile Autism, Early“[All Fields] OR “autism spectrum disorder“[All Fields] OR “Asperger“[All Fields] OR “Asperger syndrome“[All Fields] OR “childhood disintegrative disorder“[All Fields] OR “pervasive developmental disorder not otherwise specified“[All Fields] OR “Rett syndrome“[All Fields] OR “PDD-NOS“[All Fields]) AND (“prevalence“[All Fields] OR “morbidity“[All Fields] OR “epidemiology“[All Fields] OR “cross-sectional study“[All Fields]) AND (“china“[All Fields] OR “chinese“[All Fields]).

The inclusion criteria for the studies was as follows: (1) studies that clearly reported the prevalence of ASD or its subtypes; (2) study participants who were children aged < 14 years from mainland China; (3) studies published in either Chinese or English; and (4) full-text articles published between January 1, 2017, and April 8, 2023.

The exclusion criteria for the studies was as follows: (1) studies with incomplete data; (2) duplicate studies or data, such as repeated data from the same study or retaining only the study with the largest sample size for the same population; and (3) secondary sources such as reviews, case reports, and conference proceedings.

Literature screening, data extraction, and quality assessment

Two clinical physicians independently performed the literature screening, data extraction, and quality assessment. A third clinical physician verified the process. In case of any discrepancies, they jointly discussed and resolved the differences, or a third physician analyzed and made the final judgment. The initial screening involved excluding obviously irrelevant articles based on their titles and abstracts. Subsequently, the remaining articles were further reviewed by reading their full texts.

The extracted information from the included articles comprised the following aspects: general information, including the first author, publication date, study period, region (east/west/south/north/central/mixed), sample size, sex, age, etc., and the outcome measurement of the prevalence of autism among children.

The quality assessment of the included articles was conducted according to the criteria from the Agency for Healthcare Research and Quality (AHRQ) [21, 22]. This assessment consists of 11 items, each scored as 2 points for “yes” (meeting the criteria), 0 points for “no” (not meeting the criteria), and 1 point for “unclear” (not described in the article). The total score ranges from 0 to 22 points. Articles that scored 0–7 points were considered low quality, 8–14 points were considered moderate quality, and 15–22 points were considered high quality. This assessment was independently conducted by two evaluators. In case of discrepancies, they discussed with the third researcher until a consensus was reached.

Statistical analysis

Statistical data analysis was conducted using Review Manager 5.2 and Stata 14.0. For categorical data, odds ratios (OR) were used, and for continuous data, standardized mean differences (SMD) were employed. Effect sizes are presented with point estimates and their corresponding 95% confidence intervals (CI). Heterogeneity analysis was performed using the Q test and I2 test. If I2 = < 50%, indicating no statistically significant heterogeneity, a fixed-effects model was used. If I2 > 50%, indicating significant heterogeneity, a random-effects model was employed. Subgroup analysis or sensitivity analysis was conducted to explore the reasons for heterogeneity. Publication bias was assessed using funnel plots or Egger’s test. A significance level of P < 0.05 was considered statistically significant for differences.

Results

Literature search results and quality assessment

The initial search yielded a total of 15,190 relevant articles, of which 330 articles underwent full-text screening. Eventually, 21 articles met the inclusion criteria and were included in this systematic review. These studies encompassed a total of 349,900 children from mainland China. The quality assessment scores of the included articles ranged from 11 to 19 points, with the majority falling within the range of 12 to 17 points. The article selection process is depicted in Fig. 1. The basic information of the included articles and their quality assessment results are presented in Table 1.

Fig. 1
figure 1

Flow chart of literature screening

Full size image
Table 1 Information and quality of studies included for the systematic review
Full size table

Sample source: C, community-based; K/S, kindergarten/School; H, hospital physcial examination clinic. Sample selection method: SCS, Stratified cluster sampling; RCS, Random cluster sampling; RS, Random sampling; RSS, Random stratified sampling; CS, Cluster sampling; NA, Not available. Screening/diagnostic tools: ABC, Autism Behavior Checklist; CABS, Clancy Autism Behavior Scale; CARS, Childhood Autism Rating Scale; CHAT, Checklist for Autism in Toddlers; M-CHAT, Modified Checklist for Autism in Toddlers; CAST, Children Autism Spectrum Test; ASSQ, high function Autism Spectrum screening questionnaire; SCQ, Social Communication Questionnaire; SPT, symbolic play test; GDS, Gesell Developmental Schedules; ADOS-2, autism diagnostic observation schedule,2nd edition; ADI-R, Autism Diagnostic Interview-Revised; ASRS, Social Behavior and Communication Skills Screening Questionnair; WlSC-R, Wechsler Intelligence Scale for Children; SRS, Social Responsiveness Scale; WPPSI, Wechsler Preschool and Primary Scale of Intelligence; WSCMBD, warning sign for children mental and behavioral development Screening Questionnaire. Diagnostic criteria: CCMD-3, Chinese Classification of Mental Disorders, 3rd edition; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th edition; ICD-10, International Classification of Diseases, 10th revision.

Meta-analysis results

In this study, meta-analyses were conducted for the prevalence of autism among children, the prevalence of autism among children of both sexes, and the prevalence of autism among urban and rural children. The results were as follows:

Meta-analysis results of childhood autism prevalence

Heterogeneity test was conducted on the 21 included articles, and the results showed an I2 of 97.0% with a p value of 0.000, indicating significant heterogeneity. Sensitivity analysis was performed on the included articles, and the results remained consistent, confirming the utilization of a random-effects model for meta-analysis. The meta-analysis results revealed a prevalence rate of 0.7% (95% CI: 0.006–0.008) for childhood autism in China (Fig. 2). Sensitivity analysis demonstrated that the exclusion of any single article had no impact on the combined effect size.

Subgroup analyses were conducted based on factors including region(Eastern/Western/Southern/Northern/Midst/mixed), age (0–3 years/4–6 years/7–14 years/mixed ages), sample source (community-based/kindergarten or school/hospital physical examination clinic/mixed sources), sample selection method (stratified cluster sampling(SCS)/random cluster sampling(RCS)/ random sampling(RS)/random stratified sampling(RSS)/cluster sampling(CS)/not available(NA)), disease type (ASD/autism), diagnostic criteria (DSM-IV/DSM-V/ICD-10/CCMD-3/other), quality score ( > = 15 points/<15 points), and sample size (< 5000/>=5000–10,000/>=10,000). All subgroup analyses exhibited significant heterogeneity; thus, the random-effects model was employed to combine effect sizes (as shown in Table 1).

Region analysis

The eastern region had a prevalence rate of 0.9% (95% CI: 0.007–0.011) from 10 studies. The western region had a prevalence rate of 0.4% (95% CI: 0.002–0.005) from 2 studies. The southern region had a prevalence rate of 0.7% (95% CI: 0.004–0.009) from 1 study. The northern region had a prevalence rate of 0.5% (95% CI: 0.003–0.006) from 7 studies. The midst region had a prevalence rate of 0.3% (95% CI: 0.002–0.005) from 2 study. (Refer to Table 1; Fig. 3)

Age analysis

The 0–3 years had a prevalence rate of 1.1% (95% CI: 0.006–0.015) from 6 studies. The 4–6 years had a prevalence rate of 2.2% (95% CI: 0.005–0.039) from 3 studies. The 7–14 years had a prevalence rate of 0.3% (95% CI: 0.002–0.005) from 3 studies. Mixed age had a prevalence rate of 0.4% (95% CI: 0.003–0.006) from 9 studies.

Sample source analysis

Community-based sources showed a prevalence rate of 0.7% (95% CI: 0.004–0.009) from 8 studies. Kindergartens showed a prevalence rate of 0.9% (95% CI: 0.006–0.012) from 8 studies. Hospital physical examination clinics showed a prevalence rate of 0.7% (95% CI: 0.002–0.012) from 3 studies. Mixed sources showed a prevalence rate of 0.7% (95% CI: -0.001-0.015) from 2 studies.

Sampling selection method analysis

Stratified cluster sampling showed a prevalence rate of 0.5% (95% CI: 0.004–0.006) from 7 studies. Random cluster sampling showed a prevalence rate of 1.4% (95% CI: 0.007–0.021) from 4 studies. Cluster sampling showed a prevalence rate of 4.9% (95% CI: 0.039–0.058) from 1 study. The prevalence rates of other methods are shown in Table 1. Unclear sampling methods showed a prevalence rate of 0.6% (95% CI: 0.004–0.008).

Disease type analysis

ASD had a prevalence rate of 0.8% (95% CI: 0.007–0.010) from 18 studies. Autism had a prevalence rate of 0.7% (95% CI: 0.006–0.008) from 3 studies.

Diagnostic criteria analysis

The DSM-IV showed a prevalence rate of 5.2% (95% CI: 0.047–0.058) from 1 study. The DSM-V showed a prevalence rate of 0.4% (95% CI: 0.003–0.005) from 14 studies. The ICD-10 showed a prevalence rate of 0.4% (95% CI: -0.001-0.009) from 2 studies. The CCMD-3 showed a prevalence rate of 0.9% (95% CI: 0.005–0.013) from 1 study. Other criteria showed a prevalence rate of 1.8% (95% CI: 0.009–0.028) from 3 studies.

Quality score analysis

Studies with a quality score > = 15 points showed a prevalence rate of 0.5% (95% CI: 0.004–0.005) from 12 studies. Studies with a quality score < 15 points showed a prevalence rate of 1.4% (95% CI: 0.009–0.018) from 9 studies.

Sample size analysis

Studies with a sample size < 5000 showed a prevalence rate of 1.1% (95% CI: 0.006–0.017) from 7 studies. Studies with a sample size > = 5000–10,000 showed a prevalence rate of 1.3% (95% CI: 0.006–0.020) from 6 studies. Studies with a sample size > = 10,000 showed a prevalence rate of 0.4% (95% CI: 0.003–0.005) from 8 studies (Table 2).Further meta-regression analysis was conducted, and the results indicated that factors such as region (P = 0.000), age (P = 0.000), publication year (P = 0.000), sample size (P = 0.000), sampling selection method (P = 0.002), sample source (P = 0.000), disease type (P = 0.000), quality score (P = 0.000), and diagnostic criteria (P = 0.000) contributed to the heterogeneity in the prevalence of childhood ASD rates (Table 3).

Fig. 2
figure 2

Meta-analysis forest plot of the prevalence of childhood autism spectrum disorder (ASD) in mainland China

Full size image
Fig. 3
figure 3

Prevalence map of childhood autism spectrum disorder (ASD) in various regions in mainland China

Full size image
Table 2 Summary table of subgroup analysis of the prevalence of autism in children in mainland China
Full size table
Table 3 Results of regression analysis of the prevalence of autism in children in mainland China
Full size table

Analysis results of the comparison of the prevalence of ASD among children of both sexes

A total of 20 studies reported the prevalence rates of ASD among boys and girls. The heterogeneity test yielded a P value of 0.000 and an I² value of 69.1%, indicating significant heterogeneity. A random-effects model was employed for the analysis. The meta-analysis results revealed that the prevalence of ASD among boys was significantly higher than that among girls (OR = 3.198, 95% CI: 2.489 to 4.109, P = 0.000) (Fig. 4). Sensitivity analysis indicated that excluding any single study did not significantly affect the combined effect value.

Fig. 4
figure 4

Meta-analysis forest plot of the prevalence of autism in children of different genders in mainland China

Full size image

Subgroup analysis were conducted based on region (Eastern/Western/Southern/Northern/Midst/mixed), age (0–3 years/4–6 years/7–14 years/mixed ages), sample source (community-based/kindergarten or school/hospital physical examination clinic/mixed), sampling selection method (SCS/RCS/RS/RSS/CS/NA), disease type (ASD/autism), and diagnostic criteria (DSM-IV/DSM-V/ICD-10/CCMD-3/other). The results of subgroup analyses showed significant heterogeneity; therefore, a random-effects model was used to combine effect sizes. The subgroup analysis results are presented in Supplement 1.

Further meta-regression analysis was conducted, and the results indicated that region (P = 0.007), age (P = 0.002), sampling selection method (P = 0.009), and disease type (P = 0.010) contributed to the heterogeneity in childhood autism prevalence rates (Supplement 1).

Analysis results of the comparison of the prevalence of ASD between urban and rural children

Four studies reported the prevalence of ASD among urban and rural children. The test for heterogeneity showed P = 0.000 and I2 = 91.9%, indicating significant heterogeneity. The random-effects model was used for the meta-analysis. The results of the meta-analysis showed that there was no statistically significant difference in the prevalence of ASD between urban and rural children (OR = 1.342, 95% CI: 0.258–6.975, P = 0.727), as depicted in Fig. 5. Sensitivity analysis indicated that the exclusion of any single study did not significantly affect the combined effect size.

Fig. 5
figure 5

Meta-analysis forest plot of the prevalence comparison of autism between urban and rural children in mainland China

Full size image

Publication Bias

A funnel plot test was conducted to assess publication bias in the meta-analysis of the overall prevalence of childhood ASD. The funnel plot (Fig. 6a) displayed an asymmetric distribution, suggesting the possibility of publication bias. Further analysis using Egger’s test showed a t value of -0.96 and a P value of 0.349, indicating that the difference in publication bias was not statistically significant (Fig. 6b). The results of the trim-and-fill method also demonstrated that the combined effect size and P value remained relatively stable before and after adjustment (Fig. 6c), suggesting that the conclusions of this meta-analysis are relatively robust.

Fig. 6
figure 6

Publication bias test for the prevalence of autism in children. (a) Funnel Plot. (b) Egger Plot. (c) Trim and Fill Method

Full size image

Discussion

This study included a total of 21 articles [23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43] that included 349,900 children from 11 provinces, 3 municipalities directly under the central government, and 1 autonomous region in mainland China. Compared to previous meta-analyses [15, 44,45,46], this study evaluated the literature within the past 6 years, expanded the age range of inclusion compared to the study by Shi Huifeng et al. [45], and further subdivided potential subgroup factors that could affect the prevalence of ASD, such as age, diagnostic criteria, region, sample size, and quality scores. The results of this study showed that the prevalence of ASD among children was 5/1000 from 2017 to 2019 and 9/1000 from 2019 to the present. The overall prevalence of ASD over the past 6 years was 7/1000, which represents an upward trend compared to those in the study by Liu Xian et al. [15] in 2017 (2.65/1000) and the study by Hao Xiaohui et al. [44] in 2015 (2.88/1000). This trend is consistent with the gradually increasing global prevalence of ASD [14].

The increase in the prevalence of ASD among Chinese children in recent years may be attributed to several factors. First, the diagnostic criteria for ASD have been continuously revised, broadening the scope of the disorder. Second, the level of screening and diagnosis for ASD has improved. Third, the awareness of ASD among health care professionals and parents has increased, leading to better recognition and awareness. However, the prevalence of ASD among Chinese children remains lower than that in other countries worldwide. ADDM Network in the United States reported that the prevalence of ASD has increased annually, reaching 14.6/1000 (1/68) in 2012, 16.8/1000 (1/59) in 2014, 18.5/1000 (1/54) in 2016, 22.7/1000 (1/44) in 2018, and 27.6/1000 (1/36) in 2020 [16,17,18, 47, 48]. China’s current prevalence rate of ASD is still lower than the rate in the United States 11 years ago. The prevalence rate in the United Kingdom is also higher than that in China [49]. Studies by Uchan et al. [50] found an ASD prevalence rate of 6/1000 in North America and a median incidence rate of 6.19/1000 in Europe [51]. In Asia, South Korea reported a prevalence rate of 26.4/1000 children, which is also increasing [52, 53]. A study in Japan reported a prevalence rate of 32.2/1000 for ASD among children under 5 years [54]. Worldwide, the median male-to-female ratio of ASD prevalence is 4.2 [14]. In the United States, the reported prevalence of ASD is 3.8 times higher among boys than among girls [16], and in the UK, the sex ratio for typical autism in children is 4:1 [55]. This study showed that the 4–6 years had the highest prevalence of 22/1000, followed by the 0–3 years with 11/1000 and the years and mixed ages. This finding is consistent with the results of a nationwide survey in China, which found the highest risk in the 4–6 age group [56].China’s lower prevalence of ASD compared to that in most other countries could be attributed to several factors. First, it may be related to the age distribution of the surveyed population, with a greater focus on the 2–6 years in China, whereas international studies cover a broader age range. Second, more severe cases of ASD are diagnosed in China, such as classic and severe autism [57], while milder forms such as Asperger syndrome and mild autism tend to be underdiagnosed, potentially leading to an underestimation of ASD prevalence. Third, most epidemiological surveys in China are conducted on a regional basis, lacking a nationwide survey system with reliable prevalence monitoring. Furthermore, China lacks standardized, reliable, and validated screening tools, whereas developed countries have comprehensive case monitoring systems and utilize different monitoring methods and survey techniques. Last, the awareness of ASD and autism among caregivers and health care professionals in China is still lower than that in developed countries, and the stigma associated with these conditions might lead to deliberate concealment of the condition by parents.

This study revealed that the prevalence of ASD in the eastern region of China was 12/1000, which was higher than that in the southern, northern, midst, and western regions. The observed disparities might be attributed to variations in awareness and diagnostic capabilities for ASD across different regions. However, the differences could also be linked to the relatively limited inclusion of ASD cases and sample sizes. Further research with larger sample sizes and additional subgroup analyses is needed to confirm the variations in ASD prevalence among different regions.

ASD screening tools are widely used in global epidemiological surveys, and the choice of different screening tools can substantially influence estimates of ASD prevalence [58]. CABS is the most commonly used ASD screening tool in China [59], but its sensitivity is relatively low, and it is rarely used in foreign studies. In contrast, tools such as ADOS and ADI-R provide more comprehensive information and are extensively used in foreign research [60]. Therefore, differences in the choice of ASD and autism screening tools partially explain the disparities between domestic and foreign study results [61]. The study by Liu Xian et al. [15] demonstrated that there was no statistically significant difference in prevalence rates when applying CCMD or DSM diagnostic criteria. In contrast, this meta-analysis showed that the prevalence of ASD using DSM-V diagnostic criteria was 4 per 1000 children, which was the same as that using the ICD-10 criteria but lower than that using the DSM-IV (based on only one study), CCMD-3 (based on only one study), and other diagnostic criteria. This suggests that different diagnostic criteria may lead to variations in prevalence rates.

Subgroup analysis based on sampling sources in this study indicated that the prevalence rates among kindergarten populations were higher compared to community-based, hospital physical examination clinic, and mixed populations. This contradicts the findings of previous meta-analyses [15, 46] that indicated higher prevalence rates among populations from hospitals. This discrepancy may be attributed to several factors: (1) a larger number of kindergarten-based studies were included in this research, predominantly focusing on preschool children aged 4–6 years; (2) the hospital physical examination clinic group had a smaller sample size; (3) school-aged children with ASD are often sent to special schools; and (4) clinical symptoms in infants and toddlers might not be typical, and reluctance among parents in the community to acknowledge them could have led to data bias.

Both domestic and international studies [15, 56, 62] have shown a higher ASD prevalence in urban areas than in rural areas, possibly influenced by various environmental pressures or factors [63], such as prenatal exposure to environmental stressors [64] and lower parental education levels [65]. However, the present study indicated that there was no statistically significant difference in ASD prevalence between urban and rural areas. This could be due to the limited number of included studies and small sample sizes, as well as improvements in rural health care and public awareness of ASD in China.

The studies included in this article exhibited a high degree of heterogeneity, which is often challenging to avoid in epidemiological research [66]. To minimize this heterogeneity, we conducted subgroup analyses based on different sampling sources, sampling selection methods, publication years, age, diagnostic criteria, and quality scores. However, due to the limitations of the study designs, subgroup analysis was not performed on screening tools. The 21 studies included in this meta-analysis covered 13 provinces/cities/autonomous regions in China over the past six years, which may not provide comprehensive geographic representation. The sample sizes and representativeness of the regions were limited. Most of the studies did not account for socioeconomic or environmental variables or other relevant factors that could influence the prevalence of autism, thus restricting our ability to study their impact.

Conclusion

In summary, the prevalence of ASD in China from 2017 to 2023 was estimated to be 7/1000 children, with a male-to-female ratio of 5:1. The overall prevalence remained significantly lower than that reported in foreign countries. The results of this meta-analysis were influenced by limitations in the quantity and representativeness of the studies, as well as potential variations in screening tools and diagnostic criteria between domestic and foreign studies and the comparatively lower level of awareness of ASD in the Chinese population. It is recommended to conduct a nationally representative survey and monitoring of early childhood ASD prevalence to accurately assess its current status and trends. This will provide a more solid foundation for evaluating community service needs and for the establishment and improvement of service systems.

Data availability

Data of the studies analysed are already available in publications.

Abbreviations

ASD:

Autism spectrum disorder

AD:

autistic disorder

PDD-NOS:

pervasive developmental disorder not otherwise specified

ADDM:

the Autism and Developmental Disorders Monitoring Network

CBM:

China Biology Medicine database

CSTJ:

China Science and Technology Journal Database

CNKI:

China National Knowledge Infrastructure

AHRQ:

the Agency for Healthcare Research and Quality

OR:

odds ratios

SMD:

standardized mean differences

CI:

confidence intervals

C:

community-based

K/S:

kindergarten/School

H:

hospital physcial examination clinic

SCS:

Stratified cluster sampling

RCS:

Random cluster sampling

RS:

Random sampling

RSS:

Random stratified sampling

CS:

Cluster sampling

NA:

Not available

ABC:

Autism Behavior Checklist

CABS:

Clancy Autism Behavior Scale

CARS:

Childhood Autism Rating Scale

CHAT:

Checklist for Autism in Toddlers

M-CHAT:

Modified Checklist for Autism in Toddlers

CAST:

Children Autism Spectrum Test

ASSQ:

high function Autism Spectrum screening questionnaire

SCQ:

Social Communication Questionnaire

SPT:

symbloicplay tes

GDS:

Gesell Developmental Schedules

ADOS-2:

autism diagnostic observation schedule, 2nd edition

ADI-R:

Autism Diagnostic Interview-Revised

ASRS:

Social Behavior and Communication Skills Screening Questionnair

WlSC-R:

Wechsler Intelligence Scale for Children

SRS:

Social Responsiveness Scale

WPPSI:

Wechsler Preschool and Primary Scale of Intelligence

WSCMBD:

warning sign for children mental and behavioral development Screening Questionnaire

CCMD-3:

Chinese Classification of Mental Disorders, 3rd edition

DSM-III-R:

Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised

DSM-IV:

Diagnostic and Statistical Manual of Mental Disorders, 4th edition

DSM-V:

Diagnostic and Statistical Manual of Mental Disorders, 5th edition

ICD-10:

International Classification of Diseases, 10th revision

References

  1. First MB, Clinical Utility. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, and. Journal of Nervous & Mental Disease 2013, 201(9):727–729.

  2. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508–20.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gadow KD, DeVincent CJ, Pomeroy J. ADHD Symptom subtypes in Children with Pervasive Developmental Disorder. J Autism Dev Disord. 2006;36(2):271–83.

    Article  PubMed  Google Scholar 

  4. Zablotsky B, Bramlett MD, Blumberg SJ. The Co-occurrence of Autism Spectrum Disorder in Children with ADHD. J Atten Disord. 2017;24(1):94–103.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Thomas S, Hovinga ME, Rai D, Lee BK. Brief report: prevalence of co-occurring Epilepsy and Autism Spectrum Disorder: the U.S. National Survey of children’s Health 2011–2012. J Autism Dev Disord. 2017;47(1):224–9.

    Article  PubMed  Google Scholar 

  6. Amiet C, Gourfinkel-An I, Bouzamondo A, Tordjman S, Baulac M, Lechat P, Mottron L, Cohen D. Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry. 2008;64(7):577–82.

    Article  PubMed  Google Scholar 

  7. Aathira R, Gulati S, Tripathi M, Shukla G, Chakrabarty B, Sapra S, Dang N, Gupta A, Kabra M, Pandey RM. Prevalence of Sleep abnormalities in Indian Children with Autism Spectrum disorder: a cross-sectional study. Pediatr Neurol. 2017;74:62–7.

    Article  PubMed  Google Scholar 

  8. Krakowiak P, Goodlin-Jones B, Hertz-Picciotto I, Croen LA, Hansen RL. Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res. 2008;17(2):197–206.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Holingue C, Newill C, Lee LC, Pasricha PJ, Daniele Fallin M. Gastrointestinal symptoms in autism spectrum disorder: a review of the literature on ascertainment and prevalence. Autism Res. 2017;11(1):24–36.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Leader G, Abberton C, Cunningham S, Gilmartin K, Grudzien M, Higgins E, Joshi L, Whelan S, Mannion A. Gastrointestinal symptoms in Autism Spectrum disorder: a systematic review. Nutrients 2022, 14(7).

  11. Cong Y, Jiang ZM, Wang H, Zhu JL, Zhou X, Liu Y. Gastrointestinal problems in children with Autism Spectrum Disorder. Chin J Rehabilitation Theory Pract. 2016;22(3):257–60.

    Google Scholar 

  12. Zhou YN, Zhao HB, Jiang ZM. Research progresson common comorbidities in children with autism spectrum disorders. Chin J Child Health Care. 2020;28(5):555–8.

    Google Scholar 

  13. Solmi M, Song M, Yon DK, Lee SW, Fombonne E, Kim MS, Park S, Lee MH, Hwang J, Keller R, et al. Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries. Mol Psychiatry. 2022;27(10):4172–80.

    Article  PubMed  Google Scholar 

  14. Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, Yusuf A, Shih A, Elsabbagh M. Global prevalence of autism: a systematic review update. Autism Res. 2022;15(5):778–90.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Liu X, Lin SF, Chen WX, Can FF, Shen SX, Qiu X. Prevalence of autism spectrum disorders among children in China:a systematic review and meta-analysis. Chin J Child Health Care. 2018;26(4):402–406429.

    Google Scholar 

  16. Maenner MJ, Warren Z, Williams AR, Amoakohene E, Bakian AV, Bilder DA, Durkin MS, Fitzgerald RT, Furnier SM, Hughes MM, et al. Prevalence and characteristics of Autism Spectrum Disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020. MMWR Surveill Summ. 2023;72(2):1–14.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Maenner MJ, Shaw KA, Bakian AV, Bilder DA, Durkin MS, Esler A, Furnier SM, Hallas L, Hall-Lande J, Hudson A, et al. Prevalence and characteristics of Autism Spectrum Disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018. MMWR Surveill Summ. 2021;70(11):1–16.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Maenner MJ, Shaw KA, Baio J, Washington A, Patrick M, DiRienzo M, Christensen DL, Wiggins LD, Pettygrove S, Andrews JG, et al. Prevalence of Autism Spectrum Disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016. MMWR Surveill Summ. 2020;69(4):1–12.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zheng K. The correlate resaerch on the prevalence and risk factors of children with autistic spectrum disorders in Ningbo district. Master Ningbo University; 2019.

  20. Deng C, Chen A, Gu LP, He SH, Gao JH. A survey of autism spectrum disorder and its influencing factors among preschool children in Zhongshan City. Chin J Woman Child Health Res. 2017;28(12):1537–41.

    Google Scholar 

  21. Bindman AB. The Agency for Healthcare Research and Quality and the development of a Learning Health Care System. JAMA Intern Med 2017, 177(7).

  22. Chou R, Baker WL, Bañez LL, Iyer S, Myers ER, Newberry S, Pincock L, Robinson KA, Sardenga L, Sathe N, et al. Agency for Healthcare Research and Quality Evidence-based Practice Center methods provide guidance on prioritization and selection of harms in systematic reviews. J Clin Epidemiol. 2018;98:98–104.

    Article  PubMed  Google Scholar 

  23. Chen GH, Mu F, Shan XL, Han TT, Guan CR, Gu HT. The prevalence of autism spectrum disorder (ASD) in preschool children in Rencheng district of Jining City. J Jining Med Univ. 2022;45(5):351–353358.

    Google Scholar 

  24. Zhang YQ, Huang XL, Liu HT, Tang YW. Application of early screening and recognition for children with autism spectrum disorder in Dongguan. J Clin Pathol Res. 2021;41(7):1659–64.

    Google Scholar 

  25. Hao JQ, Fu HY, Yang WH, Huo JX, Gao L, Yu YQ. Analysis of epidemic status and influencing factors of Mongolian children with autism in central and eastern Inner Mongolia. Chin J School Health. 2021;42(7):1024–8.

    Google Scholar 

  26. Ding N, Xu H, Shen FH, Song CF, Xia Z, Bao LP, Cao J. Prevalence and influencing factors of autism spectrum disorders in preschool children in Wuhu. South China J Prev Med. 2021;47(11):1384–7.

    Google Scholar 

  27. Zou Y, Li PX, Liu Y, Shen XM, Tang J, Cheng Y. Investigation and therapeutic effect analysis of Autism Spectrum Disorder in Children aged 18 ∼36 months in Panzhihua City. Sichuan Med J. 2021;42(7):702–5.

    Google Scholar 

  28. Cao CH, He YY, Guo FY, He L, Wang D, He WX, Zhang HQ, Yang XY, Chen YN. Prevalence investigation on autism spectrum disorders in urban preschools in Xi′an. Chin J Appl Clin Pediatr. 2021;36(1):50–3.

    Google Scholar 

  29. Ying YJ, Zhu MH, Li HW. Prevalence and influencing factors of childhood autism in Yongkang from 2017 to 2019. Maternal Child Health Care China. 2021;36(11):2451–4.

    Google Scholar 

  30. Yuan LH, Li XL, Guo YJ. A Survey on the current situation of autism in preschool children in Huicheng district of Huizhou city. Advice Health. 2021;15(30):192195.

    Google Scholar 

  31. Long SM. Screening and follow-up study of autism spectrum disorder in children aged 18–30 months in Kaili city. Women’s Health 2021(4):293.

  32. Liu YM, Yang X, Zhang YH, Yang YJ, Shi Y, Zhang JJ, Zhou Y. Prevalence and influencing factors of autism spectrum disorder in primary school children in Chengguan District of Lanzhou city. China Health Vis 2021(9):233.

  33. Zhou H, Xu X, Yan W, Zou X, Wu L, Luo X, Li T, Huang Y, Guan H, Chen X, et al. Prevalence of Autism Spectrum Disorder in China: a Nationwide Multi-center Population-based study among children aged 6 to 12 years. Neurosci Bull. 2020;36(9):961–71.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Shen JH, Wu WH, Luo L, Huang XX. A Survey on the Status Quo and related factors of Autism Spectrum disorders at 2–6 years old in Qingcheng District, Qingyuan City. Med Innov China. 2020;17(26):71–7.

    Google Scholar 

  35. Liu D, Yao X, Yu H. Analysis of Screening results for Autism Spectrum Disorder in infants and toddlers aged 16–30 months in Shaoxing City. Maternal Child Health Care China. 2019;34(24):5748–9.

    Google Scholar 

  36. Song AHH, Wu ZQ, Liao W, Dong DS, Ning X, Li Y, Hao HX, Wang Z, Huang LH. A Survey on the Status of Autism among children aged 0–6 in Qinghai Province. Qinghai Med J. 2019;49(7):1–3.

    Google Scholar 

  37. Liang LD, Xian BW, Liu YD, Liu C, Tu FX, Tang XL, Chen X. Prevalence survey on school-age children with autism spectrum disorder in Wenzhou city. Zhejiang Med J. 2019;41(16):1722–6.

    Google Scholar 

  38. Jin Z, Yang Y, Liu S, Huang H, Jin X. Prevalence of DSM-5 Autism Spectrum Disorder among School-based children aged 3–12 years in Shanghai, China. J Autism Dev Disord. 2018;48(7):2434–43.

    Article  PubMed  Google Scholar 

  39. Sun P, Yang X. Investigation of Autism Spectrum disorders and their influencing factors among Preschool Children in Yongchuan District. China Health Vis. 2018;000(6):246–7.

    Google Scholar 

  40. Yang CJ, Zhang YR, Shao Z. Prevalence of autism spectrum disorders among 2–6 years old children in kindergartens of Chongqing city. Chin J Public Health. 2018;34(5):696–9.

    Google Scholar 

  41. Wen HY, Li F, Wei Y, Chen YJ. Prevalence and related factors of Autism in Preschool Children in Fengtai District. World Latest Med Inform. 2018;18(A2):18–2023.

    Google Scholar 

  42. Geng XM, He SQ, Gu YH, Wang F, Lin CN. Epidemiological Investigation and Analysis of the Prevalence of Autism Spectrum Disorder in Infants and Toddlers in Zhuhai City. Nursing Practice and Research 2018(8).

  43. Li L, Li XL, Wu WX, Cai XF, Fan XL, Wei XH, Sun TT. Cross-sectional survey of autism spectrum disorders in children aged 0–6 years in Hainan Province. Chin J Epidemiol. 2017;38(9):1187–90.

    CAS  Google Scholar 

  44. Hao XH. Prevalence of autism spectrum disorder among children in mainland China:a meta-analysis. 硕士. Chongqing Medical University; 2015.

  45. Shi HF, Zhang JX, Zhang R, Wang XL. Prevalence of autism spectrum disorders in children aged 0–6 years in China: a meta-analysis. J PEKING UNIVESITY (HEALTH SCIENCES). 2017;49(5):798–806.

    CAS  Google Scholar 

  46. Wang F, Lu L, Wang S-B, Zhang L, Ng CH, Ungvari GS, Cao X-L, Lu J-P, Hou C-L, Jia F-J, et al. The prevalence of autism spectrum disorders in China: a comprehensive meta-analysis. Int J Biol Sci. 2018;14(7):717–25.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Christensen DL, Baio J, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, et al. Prevalence and characteristics of Autism Spectrum Disorder among children aged 8 years–autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill Summ. 2016;65(3):1–23.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, Kurzius-Spencer M, Zahorodny W, Robinson Rosenberg C, White T, et al. Prevalence of Autism Spectrum Disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2014. MMWR Surveill Summ. 2018;67(6):1–23.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Kallitsounaki A, Williams DM. Autism spectrum disorder and Gender Dysphoria/Incongruence. A systematic literature review and Meta-analysis. J Autism Dev Disord. 2022;53(8):3103–17.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Duchan E, Patel DR. Epidemiology of Autism Spectrum disorders. Pediatr Clin North Am. 2012;59(1):27–43.

    Article  PubMed  Google Scholar 

  51. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcín C, Montiel-Nava C, Patel V, Paula CS, Wang C, et al. Global prevalence of Autism and other Pervasive Developmental disorders. Autism Res. 2012;5(3):160–79.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168(9):904–12.

    Article  PubMed  Google Scholar 

  53. Hong M, Lee SM, Park S, Yoon S-J, Kim Y-E, Oh I-H. Prevalence and Economic Burden of Autism Spectrum Disorder in South Korea Using National Health Insurance Data from 2008 to 2015. J Autism Dev Disord. 2019;50(1):333–9.

    Article  Google Scholar 

  54. Saito M, Hirota T, Sakamoto Y, Adachi M, Takahashi M, Osato-Kaneda A, Kim YS, Leventhal B, Shui A, Kato S et al. Prevalence and cumulative incidence of autism spectrum disorders and the patterns of co-occurring neurodevelopmental disorders in a total population sample of 5-year-old children. Molecular Autism 2020, 11(1).

  55. Scott FJ, Baron-Cohen S, Bolton P, Brayne C. Brief report: prevalence of autism spectrum conditions in children aged 5–11 years in Cambridgeshire, UK. Autism. 2002;6(3):231–7.

    Article  PubMed  Google Scholar 

  56. Li N, Chen G, Song X, Du W, Zheng X. Prevalence of autism-caused disability among Chinese children: a national population-based survey. Epilepsy Behav. 2011;22(4):786–9.

    Article  PubMed  Google Scholar 

  57. Li HH, Du L, Shan L, Feng JY, Jia FY. Current study on epidemiology of autism spectrum disorder. Chin J Clinicians(Electronic Edition). 2014;8(24):4471–4.

    Google Scholar 

  58. Dumont-Mathieu T, Fein D. Screening for autism in young children: the modified checklist for autism in toddlers (M‐CHAT) and other measures. Ment Retard Dev Disabil Res Rev. 2005;11(3):253–62.

    Article  PubMed  Google Scholar 

  59. Sun X, Allison C, Auyeung B, Matthews FE, Baron-Cohen S, Brayne C. The Mandarin Chinese version of the childhood autism spectrum test (CAST): test–retest reliability. Res Dev Disabil. 2013;34(10):3267–75.

    Article  PubMed  Google Scholar 

  60. Cai ZT, Hu LX, Wang ZF, Xie GD, Lin XW. Comparative analysis of several common screening and Assessment Scales for Childhood Autism Spectrum Disease. Chin Gen Pract. 2022;25(24):2998–3004.

    Google Scholar 

  61. Sun X, Allison C, Auyeung B, Matthews FE, Zhang Z, Baron-Cohen S, Brayne C. Comparison between a Mandarin Chinese version of the Childhood Autism Spectrum Test and the Clancy Autism Behaviour Scale in mainland China. Res Dev Disabil. 2014;35(7):1599–608.

    Article  PubMed  Google Scholar 

  62. Williams JG. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2005;91(1):8–15.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, et al. The epidemiology of Autism Spectrum disorders. Annu Rev Public Health. 2007;28(1):235–58.

    Article  PubMed  Google Scholar 

  64. Zaheer J, Kim H, Ko IO, Jo EK, Choi EJ, Lee HJ, Shim I, Woo HJ, Choi J, Kim GH, et al. Pre/post-natal exposure to microplastic as a potential risk factor for autism spectrum disorder. Environ Int. 2022;161:107121.

    Article  CAS  PubMed  Google Scholar 

  65. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, Singh GK, Strickland BB, Trevathan E, van Dyck PC. Prevalence of parent-reported diagnosis of Autism Spectrum Disorder among children in the US, 2007. Pediatrics. 2009;124(5):1395–403.

    Article  PubMed  Google Scholar 

  66. Patsopoulos NA, Evangelou E, Ioannidis JPA. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008;37(5):1148–57.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by Fujian Province Special Foundation for Natural Science Innovation Project (2016B014) and Fujian Medical University Union Hospital Fifth Batch of Key Hospital Discipline Construction Foundation (2022YYZDXK04).

Author information

Author notes

  1. Xinhong Jiang and Xianrui Chen contributed equally to this work.

Authors and Affiliations

  1. Department of Rehabilitation, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, China

    Xinhong Jiang & Nan Liu

  2. Department of Pediatric Rehabilitation, Xiamen Rehabilitation Hospital, Xiamen, 361003, Fujian, China

    Xianrui Chen

  3. Department of Pediatrics, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, Fujian, China

    Jingying Su

  4. Fujian Institute of Cerebrovascular Disease, Fuzhou, 350001, Fujian, China

    Nan Liu

  5. Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, 350001, Fujian, China

    Nan Liu

  6. Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, China

    Nan Liu

Authors
  1. Xinhong Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xianrui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jingying Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XJ XC JS and NL contributed to the design of the study. XJ and JS participated in data analysis and drafted the manuscript. XJ XC and JS participated in data collection and drafted the manuscript. All authors have read and approved the content of the manuscript.

Corresponding authors

Correspondence to Jingying Su or Nan Liu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, X., Chen, X., Su, J. et al. Prevalence of autism spectrum disorder in mainland china over the past 6 years: a systematic review and meta-analysis. BMC Psychiatry 24, 404 (2024). https://doi.org/10.1186/s12888-024-05729-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-024-05729-9

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us